Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for Hyperoxaluria and oxalosis

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Establish the Safety and Effectiveness of Reloxaliase in Patients with Enteric Hyperoxaluria

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study to Evaluate a Single Dose of DCR-PHXC in Patients with Primary Hyperoxaluria Type 3

    Rochester, MN

  3. Prospective Research Rare Kidney Stones

    Jacksonville, FL, Rochester, MN

  4. Rare Kidney Stone Consortium Patient Registry

    Rochester, MN, Jacksonville, FL

  5. Biobank Protocol, Rare Diseases Clinical Research Network

    Rochester, MN


Mayo Clinic Footer